Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When does patent for eli lilly mounjaro end?Dupixent patent extension us?Aubagio patent protection?Ipilimumab patent expries?When did the stop sampling stelara go generic?
The provided information doesn’t include enough details to identify Cardiogen 82’s first marketing authorization date or which EU country granted the initial approval.
To answer accurately, I need at least one of the following: - The full product name as used in the EU (and whether “Cardiogen 82” is the brand or a generic/atom/radiopharmaceutical reference) - The active substance (and any strength/formulation details) - The MAH/marketing authorization holder name - An authorization/registration number, or a link to the product’s EU listing With that, I can determine which EU regulator approved it first (and the date), then cite the source.
If you can share the product identifiers above, I can check the relevant public EU/regulatory listings to find: - The earliest country-level marketing authorization (first EU approval) - The MAH at the time of first approval - Whether the product later moved into a centralized/renewed authorization route
Reply with the active ingredient and dosage form (or paste the EU product label text / authorization holder). Once I have that, I’ll tell you the first EU country approval and the approval date, with a source link.
Other Questions About First :